{
    "clinical_study": {
        "@rank": "158039", 
        "acronym": "CACTUS-D", 
        "arm_group": [
            {
                "arm_group_label": "Continence promotion group education", 
                "arm_group_type": "Experimental", 
                "description": "A single 1-hour continence promotion group education workshop, facilitated by the research coordinator, aimed at changing knowledge and beliefs about urinary incontinence and different treatment options. An evidence-based self-management tool will be distributed at the end of the workshop."
            }, 
            {
                "arm_group_label": "Sham health lecture", 
                "arm_group_type": "Sham Comparator", 
                "description": "A single 1-hour group education workshop on other health topics of concern to older women such as memory, hearing, insomnia"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine whether women exposed to the continence promotion intervention will report\n      improved urinary symptoms and quality of life, and lower incontinence-related stigma and\n      falls than women who receive a control intervention at one-year post-intervention."
        }, 
        "brief_title": "Continence Across Continents to Upend Stigma and Dependency", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Urinary Incontinence", 
            "Falls", 
            "Quality of Life", 
            "Stigma"
        ], 
        "condition_browse": {
            "mesh_term": "Urinary Incontinence"
        }, 
        "detailed_description": {
            "textblock": "This is a cluster-randomized 4-site intervention study testing the effect of a\n      continence-promotion intervention on:\n\n        1. Improved urinary symptoms and quality of life\n\n        2. Reduction in falls\n\n        3. Reduction in stigma\n\n      A cost-effectiveness component will also be included"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women\n\n          -  65 years and older\n\n          -  Urinary incontinence at least once weekly\n\n        Exclusion Criteria:\n\n          -  Living in residential or long-term care\n\n          -  Received treatment for incontinence within the past year\n\n          -  Dementia or other neurological conditions that preclude the ability to provide\n             -Informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01858493", 
            "org_study_id": "ERA-AGE2 dossier28835"
        }, 
        "intervention": [
            {
                "arm_group_label": "Continence promotion group education", 
                "intervention_name": "Continence promotion group education workshop", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Sham health lecture", 
                "intervention_name": "Sham health lecture", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Urinary incontinence", 
            "Falls", 
            "Quality of life", 
            "Stigma", 
            "Community-dwelling older women", 
            "Continence promotion"
        ], 
        "lastchanged_date": "January 31, 2014", 
        "location": [
            {
                "contact": {
                    "email": "wagg@ualberta.ca", 
                    "last_name": "Adrian Wagg, MD", 
                    "phone": "780 492 5338"
                }, 
                "facility": {
                    "address": {
                        "city": "Edmonton", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T6G 2P4"
                    }, 
                    "name": "University of Alberta"
                }, 
                "investigator": {
                    "last_name": "Adrian Wagg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "joelle.dorais@criugm.ca", 
                    "last_name": "Joelle Dorais, BSc", 
                    "phone": "5143403540", 
                    "phone_ext": "4104"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H3W1W5"
                    }, 
                    "name": "Institut universitaire de g\u00e9riatrie de Montr\u00e9al"
                }, 
                "investigator": {
                    "last_name": "Cara Tannenbaum, MD, MSc", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Elodie.ROGEON@chu-poitiers.fr", 
                    "last_name": "Elodie Rogeon, BSc", 
                    "phone": "05.49.44.30.44", 
                    "phone_ext": "41234"
                }, 
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "state": "Poitou-Charentes", 
                        "zip": "86000"
                    }, 
                    "name": "Universit\u00e9 de Poitiers"
                }, 
                "investigator": {
                    "last_name": "Xavier Fritel, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Eleanor van den Heuvel <Eleanor.van.den.Heuvel@brunel.ac.uk>", 
                    "last_name": "Eleanor van den Heuvel, PhD", 
                    "phone": "01895266921"
                }, 
                "facility": {
                    "address": {
                        "city": "Uxbridge", 
                        "country": "United Kingdom", 
                        "state": "Middlesex", 
                        "zip": "UB8 3PH"
                    }, 
                    "name": "University of Brunel"
                }, 
                "investigator": {
                    "last_name": "Eleanor van den Heuvel, PhD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Canada", 
                "France", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 3 Cluster Randomised Trial Testing the Efficacy of a Continence Promotion Intervention to Improve Urinary Symptoms and Quality of Life, and Reduce Stigma and Falls in Older Community-dwelling Women With Untreated Incontinence", 
        "other_outcome": {
            "description": "Cost/QALY. Direct costs will include costs related to the intervention as well as health care resource use due to incontinence-associated falls and health care seeking for incontinence will be measured. Indirect costs will be measured such as the time lost from work for a child or spouse to accompany the participant to receive medical treatment for incontinence or falls. The change in utility from the baseline incontinent condition to improved incontinence with increased social participation and decreased stigma on quality of life will be calculated from SF6D utilities derived from the SF-12 questionnaire at baseline and 1-year follow-up. A disease-specific measure, the IQOL is currently undergoing mapping onto the SF-6D to see if it will provide a more responsive indication of improved quality of life than the generic SF-12 measure.", 
            "measure": "Cost-utility of the continence promotion intervention", 
            "safety_issue": "No", 
            "time_frame": "1-year"
        }, 
        "overall_contact": {
            "email": "cara.tannenbaum@umontreal.ca", 
            "last_name": "Cara Tannenbaum, MD, MSc", 
            "phone": "5143403540", 
            "phone_ext": "2526"
        }, 
        "overall_official": [
            {
                "affiliation": "Univerist\u00e9 de Montr\u00e9al", 
                "last_name": "Cara Tannenbaum, MD. MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Alberta", 
                "last_name": "Adrian Wagg, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Brunel University", 
                "last_name": "Eleanor van den Heuvel, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universit\u00e9 de Poitiers", 
                "last_name": "Xavier Fritel, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Quebec: Fonds de recherche en sante de Quebec", 
                "Canada: Canadian Institutes of Health Research", 
                "United Kingdom: Economic and Social Research Council", 
                "France: Institut national de prevention et d'education pour la sante"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patient global impression of improvement questionnaire Sandvik severity index ICIQ-FLUTS", 
            "measure": "Self-reported improvement in urinary incontinence", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "reference": [
            {
                "PMID": "23043154", 
                "citation": "Agnew R, van den Heuvel E, Tannenbaum C. Efficiency of using community organisations as catalysts for recruitment to continence promotion trials. Clin Trials. 2013 Feb;10(1):151-9. doi: 10.1177/1740774512460144. Epub 2012 Oct 5."
            }, 
            {
                "PMID": "24334159", 
                "citation": "Tannenbaum C, Agnew R, Benedetti A, Thomas D, van den Heuvel E. Effectiveness of continence promotion for older women via community organisations: a cluster randomised trial. BMJ Open. 2013 Dec 10;3(12):e004135. doi: 10.1136/bmjopen-2013-004135."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01858493"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal", 
            "investigator_full_name": "Cara Tannenbaum", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Reduction in incontinence-related falls measured by fall diary", 
                "measure": "Falls", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Measured with the Incontinence Quality of Life questionnaire (IQOL)", 
                "measure": "Reduction in incontinence related stigma and quality of life", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Fonds de la Recherche en Sant\u00e9 du Qu\u00e9bec", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical Research Council", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Canadian Institutes of Health Research  (CIHR)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Institut national de prevention et d'education pour la sante", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}